Company
wavebreak
Stopping the wave of neurodegeneration at its source
- Status
- Operatingas of 2026-09-19
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
We are taking an entirely new approach to treating neurodegeneration, targeting the fleeting protein intermediates that are central to many neurodegenerative disease pathways but have been beyond the reach of conventional drug discovery approaches until now.
Loading relationship preview